Odensomab 60 Mg Injection

Product Description

Prolia Solution for Injection is a medicine used in the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. It makes the bones strong and reduce the risk of fractures.

How Odensomab 60 Mg Injection Works

Odensomab contains denosumab, a monoclonal antibody that inhibits bone resorption by targeting specific cells responsible for bone breakdown. This mechanism effectively strengthens bones and reduces the risk of fractures, making it a valuable treatment option for individuals with osteoporosis. Its targeted biological action promotes healthier bone density over time.


Recommended Usage and Dosage Guidelines

The standard regimen for Odensomab is a 60 mg subcutaneous injection administered every six months, as directed by a healthcare professional. This dosing schedule is designed to maintain optimal bone health and reduce the likelihood of fracture. It is essential for patients to follow the physician's instructions closely for maximum benefit and safety.


Storage and Handling Instructions

Odensomab must be stored at a temperature between 2C to 8C and kept protected from light. It is important not to freeze the medicine. Accurate storage ensures its effectiveness and stability for up to 24 months. Always keep the injection in its original packaging until ready for use.